Categories

Abbott Medical Recalls Dragonfly OpStar Imaging Catheter for Potential Loose Catheter Marker Band That May Cause Patient Harm

The Dragonfly OpStar imaging catheter is used to image coronary arteries. A marker band on it may become loose during use, which may cause harm to the patient.

http://www.fda.gov/medical-devices/medical-device-recalls/abbott-medical-recalls-dragonfly-opstar-imaging-catheter-potential-loose-catheter-marker-band-may

 
Categories

Urgent Voluntary Recall: CorneaGen Cornea/ Cornea Patch Grafts; CorneaGen is voluntarily recalling Corneal Patch Grafts bearing the following product numbers: W419221004861104; W419221004861105; W419221004861106; W419221004861103

On January 5, 2022, CorneaGen discovered that Cornea Patch Grafts were obtained from a donor who tested reactive for HIV-1/HIV-2 Plus O antibody and were shipped prior to being medically cleared.

http://www.fda.gov/vaccines-blood-biologics/recalls-biologics/urgent-voluntary-recall-corneagen-cornea-cornea-patch-grafts-corneagen-voluntarily-recalling-corneal

 
Categories

Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules, USP 0.5 mg Due to Dissolution Test Failure

Teva Pharmaceuticals USA has initiated a voluntary nationwide recall of a single lot of Anagrelide Capsules, USP 0.5 mg (Lot number GD01090), to the consumer level in the United States. This voluntary recall was initiated due to dissolution test failure detected during routine stability testing. No

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-issues-voluntary-nationwide-recall-one-lot-anagrelide-capsules-usp-05-mg-due-dissolution-test